Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,261Revenue (TTM) $M7.7Net Margin (%)-1,324.0Altman Z-Score56.9
Enterprise Value $M1,134EPS (TTM) $-2.5Operating Margin %-1,296.6Piotroski F-Score4
P/E(ttm)--Beneish M-Score-2.6Pre-tax Margin (%)-1,324.0Higher ROA y-yY
Price/Book8.110-y EBITDA Growth Rate %-15.2Quick Ratio11.9Cash flow > EarningsY
Price/Sales1055-y EBITDA Growth Rate %-4.8Current Ratio11.9Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-75.2Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-88.9Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M60.5ROIC % (ttm)-1,566.6Gross Margin Increase y-yN

Gurus Latest Trades with DVAX

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

DVAX is held by these investors:



DVAX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Janssen RobertVice President 2017-01-24Buy6,000$4.04416.09view
Janssen RobertVice President 2016-06-28Buy1,452$13.6852.41view
Gray EddieCEO and Director 2016-05-20Buy2,750$15.5733.91view
Janssen RobertVice President 2016-05-12Buy1,000$15.1237.9view
Janssen RobertVice President 2015-10-08Buy100$23.34-10.67view
Gray EddieCEO and Director 2014-08-14Buy2,500$14.939.93view
KISNER DANIEL LDirector 2013-10-30Buy1,000$10.893.06view
ORONSKY ARNOLD LDirector 2013-10-30Buy18,605$10.893.06view
Phillips Peggy VDirector 2013-10-30Buy9,302$10.893.06view
Janssen RobertChief Medical Officer and VP 2013-07-09Sell0$093.06view

Press Releases about DVAX :

Quarterly/Annual Reports about DVAX:

News about DVAX:

Articles On GuruFocus.com
Dynavax Technologies Skyrockets on Hepatitis B Vaccine Jul 31 2017 
What Dynavax Technologies Holders Need to Consider Heading Into the Heplisav-B PDUFA Apr 03 2017 
Trump Victory Gives Life to Pharma,Biotech - Take a Look at VBI Vaccines Nov 11 2016 
Steven Cohen Increases Position in Dynavax Oct 07 2016 
VBI Vaccines: The Safer Alternative to the Struggling Dynavax Technologies Sep 06 2016 
Dynavax Initiates Immuno-Oncology Clinical Trial Evaluating SD-101 in Combination With Merck's Anti- Oct 08 2015 
Dynavax to Participate in Two Upcoming Investor Conferences Sep 03 2015 
Dynavax Reports Second Quarter 2015 Financial Results Aug 07 2015 
Dynavax Prices Public Offering of Common Stock Jul 22 2015 
Dynavax Announces Proposed Public Offering of Common Stock Jul 21 2015 

More From Other Websites
ETFs with exposure to Dynavax Technologies Corp. : September 15, 2017 Sep 15 2017
3 Biotech Stocks I'd Buy Right Now Sep 15 2017
Are Options Traders Betting on a Big Move in Dynavax (DVAX) Stock? Sep 14 2017
3 Biotech Stocks That Have Already Quadrupled in 2017 Sep 13 2017
Dynavax: Buy On Weakness Ahead Of November's PDUFA Date Sep 13 2017
Is It Time To Buy Dynavax Technologies Corporation (DVAX)? Sep 12 2017
Harry Boxer: 4 breakout charts to watch Sep 06 2017
Federman & Sherwood Announces Settlement in Dynavax Shareholder Derivative Action Sep 05 2017
Dynavax to Present at Upcoming Investor Conferences Sep 05 2017
Here Are 3 Strong Biotech Stocks In 2017 Sep 04 2017
Robbins Arroyo LLP Announces Settlement in Dynavax Technologies Corporation (DVAX) Shareholder... Sep 01 2017
ETFs with exposure to Dynavax Technologies Corp. : August 31, 2017 Aug 31 2017
Dynavax Technologies Corp. :DVAX-US: Earnings Analysis: Q2, 2017 By the Numbers : August 24, 2017 Aug 24 2017
Dynavax Announces Exercise in Full of Over-Allotment Option and Completion of Public Offering of... Aug 15 2017
Dynavax Prices Public Offering of Common Stock Aug 09 2017
Biotech Stock Roundup: Q2 Earnings from Regeneron, Kite & More, FibroGen Up on IPF Data Aug 09 2017
5 Top Stocks for August Aug 08 2017
Dynavax Announces Proposed Public Offering of Common Stock Aug 08 2017
Dynavax Technologies (DVAX) Catches Eye: Stock Adds 11.2% in Session Aug 08 2017
Today's Research Reports on Trending Tickers: Dynavax Technologies and Valeant Pharmaceuticals Aug 04 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}